These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 399955)

  • 21. Metabolism of mutagens and carcinogens in woodchuck liver and its relationship with hepatitis virus infection.
    De Flora S; Camoirano A; Romano M; Astengo M; Cesarone CF; Millman I
    Cancer Res; 1987 Aug; 47(15):4052-8. PubMed ID: 3607750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mutagenicity of alkylnitrites in the Salmonella test].
    Quinto I
    Boll Soc Ital Biol Sper; 1980 Apr; 56(8):816-20. PubMed ID: 7004467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased production of mutagenic metabolites of carcinogens by tissues from senescent rodents.
    Baird MB; Birnbaum LS
    Cancer Res; 1979 Nov; 39(11):4752-5. PubMed ID: 498103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of carcinogens and mutagens by rat colon mucosa.
    Fang WF; Strobel HW
    Cancer Res; 1978 Sep; 38(9):2939-44. PubMed ID: 354782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of nutritional status on mutagenicity of urine excreted by rats treated with standard/experimental carcinogens.
    Ammigan N; Nagabhushan M; Nair UJ; Amonkar AJ; Bhide SV
    Indian J Exp Biol; 1990 Aug; 28(8):711-3. PubMed ID: 2253960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of mutagenic and antimutagenic activities of alpha-bisabolol in the Salmonella/microsome assay.
    Gomes-Carneiro MR; Dias DM; De-Oliveira AC; Paumgartten FJ
    Mutat Res; 2005 Aug; 585(1-2):105-12. PubMed ID: 15936245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro effects of N-acetylcysteine on the mutagenicity of direct-acting compounds and procarcinogens.
    De Flora S; Bennicelli C; Zanacchi P; Camoirano A; Morelli A; De Flora A
    Carcinogenesis; 1984 Apr; 5(4):505-10. PubMed ID: 6368036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Literature survey of bacterial, fungal, and Drosophila assay systems used in the evaluation of selected chemical compounds for mutagenic activity.
    Brown MM; Wassom JS; Malling HV; Shelby MD; Von Halle ES
    J Natl Cancer Inst; 1979 Apr; 62(4):841-71. PubMed ID: 155170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical characterization of 465 known or suspected carcinogens and their correlation with mutagenic activity in the Salmonella typhimurium system.
    Rinkus SJ; Legator MS
    Cancer Res; 1979 Sep; 39(9):3289-318. PubMed ID: 383284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutagenicity of cancer chemotherapeutic agents in the Salmonella/microsome test.
    Benedict WF; Baker MS; Haroun L; Choi E; Ames BN
    Cancer Res; 1977 Jul; 37(7 Pt 1):2209-13. PubMed ID: 193638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the mutagenicity and DNA-modifying activity of carcinogens and noncarcinogens in microbial systems.
    Rosenkranz HS; Poirier LA
    J Natl Cancer Inst; 1979 Apr; 62(4):873-92. PubMed ID: 372656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic activation and deactivation of mutagens by preparations of human lung parenchyma and bronchial tree.
    De Flora S; Bennicelli C; Zanacchi P; Camoirano A; Petruzzelli S; Giuntini C
    Mutat Res; 1984 Jan; 139(1):9-14. PubMed ID: 6361547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary studies on the ability of Drosophila microsomal preparations to activate mutagens and carcinogens.
    Baars AJ; Blijleven WG; Mohn GR; Natarajan AT; Breimer DD
    Mutat Res; 1980 Sep; 72(2):257-64. PubMed ID: 6777691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible involvement of a vicinal, non-bay-region dihydrodiol-epoxide in the activation of dibenzo[a,e]fluoranthene into bacterial mutagens.
    Malaveille C; Hautefeuille A; Perin-Roussel O; Saguem S; Croisy-Delcey M; Zajdela F; Bartsch H
    Carcinogenesis; 1984 Oct; 5(10):1263-6. PubMed ID: 6386214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of mutagenic impurities in carcinogens and noncarcinogens by high-pressure liquid chromatography and the Salmonella/microsome test.
    Donahue EV; McCann J; Ames BN
    Cancer Res; 1978 Feb; 38(2):431-8. PubMed ID: 340030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutagenic activity of chemical carcinogens and related compounds in the intraperitoneal host-mediated assay.
    Simmon VF; Rosenkranz HS; Zeiger E; Poirier LA
    J Natl Cancer Inst; 1979 Apr; 62(4):911-8. PubMed ID: 372659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic activation of chemical carcinogens by hepatic preparations from streptozotocin-treated rats.
    Flatt PR; Bass SL; Ayrton AD; Trinick J; Ioannides C
    Diabetologia; 1989 Feb; 32(2):135-9. PubMed ID: 2524416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of carcinogens and related compounds tested for mutagenic activity.
    Poirier LA; Weisburger EK
    J Natl Cancer Inst; 1979 Apr; 62(4):833-40. PubMed ID: 372655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Salmonella typhimurium--test system for detecting the mutagenic activity of environmental pollutants. II. Mutagenic effect of heavy metal salts in an in vitro system with metabolic activation].
    Polukhina GN; Kalinina LM; Lukasheva LI
    Genetika; 1977; 13(8):1492-4. PubMed ID: 334635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1,2-dihydro-1,2-dihydroxy-5-methylchrysene, a major activated metabolite of the environmental carcinogen 5-methylchrysene.
    Hecht SS; LaVoie E; Mazzarese R; Amin S; Bedenko V; Hoffmann D
    Cancer Res; 1978 Jul; 38(7):2191-4. PubMed ID: 350385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.